Largest pharmaceutical companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
AbbVie has the lowest figure of the 61 pharmaceutical companies ranked by net assets, at -SGD 4.2B, followed by BridgeBio Pharma (-SGD 2.7B) and Cytokinetics (-SGD 850.5M). Figures as of 18 Nov 2026, 17:47 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- AbbVie-SGD 4.2B
- Median
- SGD 1.1B
- Combined market value
- SGD 6.56T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | -SGD 4.2B | SGD 656.1B | SGD 371.17 | 1.69% down | 26% up | ||
| 2 | BridgeBio PharmaBBIO · Health Care | -SGD 2.7B | SGD 19.6B | SGD 100.51 | 1.50% up | 17% up | ||
| 3 | CytokineticsCYTK · Health Care | -SGD 850.5M | SGD 9.3B | SGD 66.59 | 0.01% down | 20% down | ||
| 4 | PTC TherapeuticsPTCT · Health Care | -SGD 264.7M | SGD 6.5B | SGD 77.97 | 0.18% up | 20% down | ||
| 5 | Ascendis PharmaASND · Health Care | -SGD 232.9M | SGD 23B | SGD 350.02 | 0.11% up | 28% up | ||
| 6 | VeradermicsMANE · Health Care | -SGD 156M | SGD 6.7B | SGD 159.86 | 1.31% down | 233% up | ||
| 7 | Amneal PharmaceuticalsAMRX · Health Care | -SGD 91.3M | SGD 9.9B | SGD 28.34 | 4.07% up | 83% up | ||
| 8 | Axsome TherapeuticsAXSM · Health Care | SGD 113.8M | SGD 9.1B | SGD 172.43 | 1.63% down | 7% down | ||
| 9 | Travere TherapeuticsTVTX · Health Care | SGD 148.1M | SGD 6.3B | SGD 66.05 | 0.25% up | 44% up | ||
| 10 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 179.3M | SGD 10.6B | SGD 153.56 | 2.14% up | 13% up | ||
| 11 | Mirum PharmaceuticalsMIRM · Health Care | SGD 405.7M | SGD 7.8B | SGD 118.73 | 0.15% up | 31% up | ||
| 12 | ErascaERAS · Health Care | SGD 419.2M | SGD 6B | SGD 17.15 | 4.25% down | 403% up | ||
| 13 | Definium TherapeuticsDFTX · Health Care | SGD 428.5M | SGD 5.1B | SGD 37.53 | 0.92% down | 169% up | ||
| 14 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 600.9M | SGD 7.9B | SGD 56.15 | 1.30% up | 10% up | ||
| 15 | Oruka TherapeuticsORKA · Health Care | SGD 608.5M | SGD 8.6B | SGD 126.35 | 1.74% up | 241% up | ||
| 16 | Ionis PharmaceuticalsIONS · Health Care | SGD 630.6M | SGD 5.9B | SGD 35.57 | 2.34% up | 64% down | ||
| 17 | Dianthus TherapeuticsDNTH · Health Care | SGD 636.2M | SGD 6.3B | SGD 112.49 | 0.31% up | 113% up | ||
| 18 | ABIVAXABVX · Health Care | SGD 651.2M | SGD 9.5B | SGD 108.33 | 2.34% up | 27% down | ||
| 19 | Edgewise TherapeuticsEWTX · Health Care | SGD 673.4M | SGD 5.9B | SGD 53.98 | 0.40% down | 88% up | ||
| 20 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 731.8M | SGD 9.7B | SGD 123.16 | 0.44% up | 126% up | ||
| 21 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 777.1M | SGD 12.2B | SGD 524.20 | 3.65% down | 24% down | ||
| 22 | Protagonist TherapeuticsPTGX · Health Care | SGD 792.6M | SGD 10.6B | SGD 161.71 | 0.60% up | 46% up | ||
| 23 | Cogent BiosciencesCOGT · Health Care | SGD 820.5M | SGD 6.3B | SGD 36.46 | 1.54% up | 20% down | ||
| 24 | Corcept TherapeuticsCORT · Health Care | SGD 835.2M | SGD 9.6B | SGD 88.13 | 2.45% down | 8% down | ||
| 25 | TG TherapeuticsTGTX · Health Care | SGD 835.5M | SGD 12.9B | SGD 85.42 | 5.65% up | 107% up | ||
| 26 | Summit TherapeuticsSMMT · Health Care | SGD 849.5M | SGD 11B | SGD 13.76 | 0.05% up | 36% down | ||
| 27 | Spyre TherapeuticsSYRE · Health Care | SGD 922.2M | SGD 11.9B | SGD 125.59 | 3.83% up | 286% up | ||
| 28 | InsmedINSM · Health Care | SGD 952.8M | SGD 34.2B | SGD 156.01 | 0.70% down | 40% down | ||
| 29 | Belite BioBLTE · Health Care | SGD 993.4M | SGD 8.3B | SGD 204.27 | 0.45% up | 31% up | ||
| 30 | Alnylam PharmaceuticalsALNY · Health Care | SGD 1B | SGD 26.3B | SGD 196.16 | 2.79% down | 66% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | SGD 1.1B | SGD 11.1B | SGD 397.83 | 1.15% up | 61% up | ||
| 32 | Legend BiotechLEGN · Health Care | SGD 1.3B | SGD 4.1B | SGD 20.91 | 0.68% up | 42% down | ||
| 33 | Ligand PharmaceuticalsLGND · Health Care | SGD 1.3B | SGD 7.8B | SGD 387.71 | 2.35% up | 43% up | ||
| 34 | AlkermesALKS · Health Care | SGD 2.3B | SGD 10.2B | SGD 60.42 | 3.10% up | 58% up | ||
| 35 | ZoetisZTS · Health Care | SGD 4.3B | SGD 44.4B | SGD 109.33 | 1.58% up | 29% down | ||
| 36 | Dr. Reddy's LaboratoriesRDY · Health Care | SGD 5.2B | SGD 16.1B | SGD 19.36 | 1.52% up | 5% up | ||
| 37 | Jazz PharmaceuticalsJAZZ · Health Care | SGD 5.6B | SGD 20.4B | SGD 317.76 | 2.39% up | 37% up | ||
| 38 | BeOne MedicinesONC · Health Care | SGD 5.6B | SGD 59.7B | SGD 523.00 | 1.84% down | 17% up | ||
| 39 | Roivant SciencesROIV · Health Care | SGD 5.8B | SGD 36.1B | SGD 49.88 | 0.06% down | 90% up | ||
| 40 | GenmabGMAB · Health Care | SGD 7.5B | SGD 40.9B | SGD 66.40 | 0.89% down | 70% up | ||
| 41 | GrifolsGRFS · Health Care | SGD 7.5B | SGD 7.4B | SGD 10.92 | 1.85% down | 1% up | ||
| 42 | BioMarin PharmaceuticalBMRN · Health Care | SGD 7.8B | SGD 15.1B | SGD 78.19 | 3.65% up | 11% up | ||
| 43 | Elanco Animal HealthELAN · Health Care | SGD 8.4B | SGD 17.3B | SGD 34.58 | 3.75% up | 20% up | ||
| 44 | United TherapeuticsUTHR · Health Care | SGD 9.1B | SGD 31.9B | SGD 749.11 | 0.53% down | 23% up | ||
| 45 | Teva Pharmaceutical IndustriesTEVA · Health Care | SGD 10.2B | SGD 63.6B | SGD 54.52 | 0.79% down | 74% up | ||
| 46 | Royalty PharmaRPRX · Health Care | SGD 12.5B | SGD 51.4B | SGD 89.36 | 0.92% up | 78% up | ||
| 47 | ViatrisVTRS · Health Care | SGD 19B | SGD 30.7B | SGD 26.75 | 1.44% up | 96% up | ||
| 48 | Bristol-Myers SquibbBMY · Health Care | SGD 23.8B | SGD 158.1B | SGD 77.35 | 2.22% down | 34% up | ||
| 49 | Vertex PharmaceuticalsVRTX · Health Care | SGD 24.1B | SGD 175.4B | SGD 691.64 | 0.42% up | 27% up | ||
| 50 | GSKGSK · Health Care | SGD 28B | SGD 126.1B | SGD 62.91 | 0.91% down | 6% up | ||
| 51 | Eli LillyLLY · Health Care | SGD 34.2B | SGD 1.6T | SGD 1,792.86 | 1.77% down | 35% up | ||
| 52 | Novo NordiskNVO · Health Care | SGD 37.1B | SGD 225B | SGD 51.04 | 2.73% down | 17% down | ||
| 53 | Regeneron PharmaceuticalsREGN · Health Care | SGD 40.3B | SGD 126.6B | SGD 1,223.87 | 0.89% down | 36% up | ||
| 54 | NovartisNVS · Health Care | SGD 59.5B | SGD 379.9B | SGD 201.13 | 1.97% down | 25% up | ||
| 55 | Takeda PharmaceuticalTAK · Health Care | SGD 60B | SGD 88.2B | SGD 27.59 | 1.11% down | 54% up | ||
| 56 | AstraZenecaAZN · Health Care | SGD 62.7B | SGD 358.9B | SGD 231.38 | 1.54% down | 2% up | ||
| 57 | Abbott LaboratoriesABT · Health Care | SGD 67.2B | SGD 233.6B | SGD 134.86 | 0.11% down | 17% down | ||
| 58 | Merck & CoMRK · Health Care | SGD 67.8B | SGD 441.3B | SGD 178.99 | 3.17% down | 51% up | ||
| 59 | SanofiSNY · Health Care | SGD 102.1B | SGD 146.5B | SGD 61.02 | 0.43% down | 4% down | ||
| 60 | Johnson & JohnsonJNJ · Health Care | SGD 105.1B | SGD 857B | SGD 355.98 | 0.93% down | 38% up | ||
| 61 | PfizerPFE · Health Care | SGD 111.5B | SGD 207B | SGD 36.31 | 1.07% down | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2893 SGD).
Questions and answers
Which pharmaceutical companies have the lowest net assets?
AbbVie (-SGD 4.2B), BridgeBio Pharma (-SGD 2.7B) and Cytokinetics (-SGD 850.5M) have the lowest net assets of the 61 pharmaceutical companies ranked here as of 18 Nov 2026, 17:47 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by net assets.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by net assets have a combined market value of SGD 6.56T as of 18 Nov 2026, 17:47 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.